OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

PROGRESSIVE CORP. DL 1/  US7433151039  /

Hannover
2024-06-14  8:03:32 AM Chg. 0.00 Volume Bid9:59:59 PM Ask9:59:59 PM Market Capitalization Dividend Y. P/E Ratio
188.98EUR 0.00% 0
Turnover: 0.00		 -Bid Size: - -Ask Size: - 111.56 bill.EUR - -
GlobeNewswire 06-14 Progressive Reports May 2024 Results
GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 06-10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire 06-10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
TeleTrader 06-09 EP updated results, EPP with 189 seats
TeleTrader 06-09 EPP's Weber claims party victory in EP election
GlobeNewswire 06-07 TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 06-07 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire 06-06 Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...
GlobeNewswire 06-06 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire 06-05 The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening
GlobeNewswire 06-05 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire 06-05 Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
GlobeNewswire 06-04 Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intrana...
GlobeNewswire 06-04 Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...
GlobeNewswire 06-03 Opthea To Present at Clinical Trials at the Summit Meeting
GlobeNewswire 06-03 TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 06-03 MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...
GlobeNewswire 05-31 TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire 05-30 Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...